Emilie Toresson Grip

Om mig
Publikationer
Populärvetenskap och samverkan

Om mig

Industrial PhD student with focus on epidemiology, risks and economic burden
of chronic liver disease, using data from regional electronic health care
charts and national administrative health and population registers. Part of
the Hagström Group (www.ki.se/en/medh/hagstrom-group [1])
Also working as Director, Head of Real World Data and Analytics Unit at
Quantify Research (www.quantifyresearch.com [2]).
[1] https://ki.se/en/medh/hagstrom-group
[2] www.quantifyresearch.com

Artiklar

Article: DIABETES CARE. 2024;47(6):978-985
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes
Shang Y; Grip ET; Modica A; Skroder H; Strom O; Ntanios F; Gudbjornsdottir S; Hagstrom H
Article: GUT. 2024;73(5):835-843
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes
Wester A; Shang Y; Grip ET; Matthews AA; Hagstrom H
Article: JOURNAL OF DIABETES RESEARCH. 2024;2024:6142211
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study.
Langslet G; Nyström T; Vistisen D; Carstensen B; Grip ET; Casajust P; Tskhvarashvili G; Hoti F; Klement R; Karlsdotter K; Tuovinen M; Ofstad AP; Lajer M; Shay C; Koeneman L; Farsani SF; Niskanen L; Halvorsen S
Article: SCANDINAVIAN JOURNAL OF PAIN. 2023;23(4):694-704
Economic burden of osteoarthritis - multi-country estimates of direct and indirect costs from the BISCUITS study
Hallberg S; Rolfson O; Karppinen J; Schiottz-Christensen B; Stubhaug A; Toresson Grip E; Robinson RL; De Geer A; Schepman P
Article: SCANDINAVIAN JOURNAL OF PAIN. 2023;23(2):353-363
Problematic opioid use among osteoarthritis patients with chronic post-operative pain after joint replacement: analyses from the BISCUITS study
Hansen JL; Heilig M; Kalso E; Stubhaug A; Knutsson D; Sandin P; Dorling P; Beck C; Grip ET; Blakeman KH; Arendt-Nielsen L
Article: SCANDINAVIAN JOURNAL OF PAIN. 2023;23(1):126-138
Burden of disease and management of osteoarthritis and chronic low back pain: healthcare utilization and sick leave in Sweden, Norway, Finland and Denmark (BISCUITS): study design and patient characteristics of a real world data study
Hallberg S; Rolfson O; Karppinen J; Schiottz-Christensen B; Stubhaug A; Fischer MR; Gerdle B; Grip ET; Gustavsson A; Robinson RL; Varenhorst C; Schepman P
Article: DIABETES OBESITY & METABOLISM. 2023;25(1):261-271
Empagliflozin reduces cardiorenal events, healthcare resource use and mortality in Sweden compared to dipeptidyl peptidase-4 inhibitors: Real world evidence from the Nordic EMPRISE study
Nystrom T; Toresson Grip E; Gunnarsson J; Casajust P; Karlsdotter K; Skogsberg J; Ustyugova A
Article: INTERNATIONAL UROGYNECOLOGY JOURNAL. 2021;32(11):3007-3015
Association between surgical volumes and real-world healthcare cost when using a mesh capturing device for pelvic organ prolapse: A 5-years comparison between single- versus multicenter use
Morcos E; Falconer C; Grip ET; Geale K; Hellgren K; Poutakidis G; Altman D
Journal article: VALUE IN HEALTH. 2020;23:s597
PMS26 BISCUITS - a large Nordic cohort study assessing burden, outcomes, and disease management for patients with osteoarthritis and chronic low back pain: Patient characteristics and prevalence in Sweden
Hallberg S; Rolfson O; Karppinen J; Schiøttz-Christensen B; Stubhaug A; Grip ET; Gustavsson A; Robinson RL; Varenhorst C; Emir B; Schepman P
Article: DIABETES CARE. 2019;42(4):545-552
Real-World Costs of Continuous Insulin Pump Therapy and Multiple Daily Injections for Type 1 Diabetes: A Population-Based and Propensity-Matched Cohort From the Swedish National Diabetes Register.
Toresson Grip E; Svensson A-M; Miftaraj M; Eliasson B; Franzén S; Gudbjörnsdottir S; Steen Carlsson K

Alla övriga publikationer

Letter: JOURNAL OF HEPATOLOGY. 2025;83(2):e95-e97
Potential issues with implementation of EASL-EASD-EASO guidelines on management of MASLD in patients with type 2 diabetes in Sweden
Roeren M; Grip ET; Skroder H; Shang Y; Hagstrom H
Conference publication: HEPATOLOGY. 2022;76:S620-S621
ADDITIONAL COMPONENTS OF THE METABOLIC SYNDROMES INCREASE THE RISK FOR SEVERE LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES IN A DOSE-DEPENDENT MANNER
Shang Y; Toresson-Grip E; Ntanios F; Modica A; Strom O; Hagstrom H
Meeting abstract: DIABETES. 2018;67
Cost-Effectiveness of Once-Weekly Semaglutide 1.0 mg vs. Dulaglutide 1.5 mg as Add-On to Metformin in the Treatment of Type 2 Diabetes in Canada
Johansen P; Hakan-Bloch J; Liu AR; Persson S; Grip ET

Om mig

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI